Sg Americas Securities, LLC Freeline Therapeutics Holdings PLC Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
SELL
$0.69 - $1.12 $5,310 - $8,620
-7,697 Reduced 12.97%
51,663 $45,000
Q1 2022

Apr 29, 2022
BUY
$0.92 - $2.03 $4,402 - $9,713
4,785 Added 8.77%
59,360 $66,000
Q4 2021

Feb 07, 2022
BUY
$1.97 - $3.45 $14,154 - $24,788
7,185 Added 15.16%
54,575 $108,000
Q3 2021

Nov 01, 2021
BUY
$3.04 - $8.9 $144,065 - $421,771
47,390 New
47,390 $163,000

Others Institutions Holding FRLN

# of Institutions
1
Shares Held
30.1K
Call Options Held
0
Put Options Held
0
View Full List

About Freeline Therapeutics Holdings plc

FRLN Quotes by TradingView
  • Ticker FRLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,972,300
  • Description
  • Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in P...
More about FRLN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email